Search across episodes, people, companies, and topics — or ask the AI agent for deeper research and structured analysis.

Browse all available podcasts, episodes, and categories. Explore Technology shows and discover new content to follow.

Manage your subscribed podcasts. New episodes are automatically analyzed with AI when published, so you never miss important discussions.

Your AI analysis feed. Every episode you analyze appears here with key insights, summaries, and extracted intelligence.

Browse individuals mentioned across analyzed episodes. See who's being discussed, in what context, and how often.

Track companies and organizations referenced in podcast discussions. Monitor brand mentions and competitive intelligence.

Explore recurring topics and themes extracted from analyzed episodes. Discover what subjects are driving podcast conversations.

Spot emerging trends identified by AI across analyzed episodes. See what's gaining momentum in podcast discussions.

Browse brands and advertisers identified across analyzed episodes. See which companies sponsor which shows and how often.

Hone Health

Mentioned in 2 analyzed podcast episodes across 2 shows

Mentioned On

My First Million Mind Pump: Raw Fitness Truth

Episode Mentions

My First Million

My First Million · Apr 27, 2026

How to find your thing

“Telehealth platform for testosterone replacement therapy; mentioned as profitable investment opportunity identified through frontier exploration”

Finding your professional calling without entrepreneurshipBliss vs. blisters framework for identifying sustainable workWork loops and repeatable job structures

Mind Pump: Raw Fitness Truth

Mind Pump: Raw Fitness Truth · Feb 26, 2026

2802: The State of the Hormone & Peptide Industry w/ Vita Bella Founder Phil Vella

“Competitor offering membership-based model but limited to testosterone and one other medication, not comprehensive like Vita Bella”

Peptide pricing transparency and cost structure analysisQuality control and third-party testing in gray-market peptidesGLP-1 monotherapy risks and combination protocol design